New injection tested for Tough-to-Treat blood cancer
NCT ID NCT06223516
Summary
This early-stage study is testing a new drug called etentamig (ABBV-383) in people with multiple myeloma that has come back or stopped responding to other treatments. About 60 participants will receive the drug as an injection under the skin or through an IV to check its safety, how the body processes it, and if it helps control the cancer. The main goal is to understand the side effects and the right dose, not to cure the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atrium Health Wake Forest Baptist Medical Center /ID# 260807
Winston-Salem, North Carolina, 27157, United States
-
Hadassah Medical Center-Hebrew University /ID# 261446
Jerusalem, Jerusalem, 91120, Israel
-
Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital /ID# 265286
Nagoya, Aichi-ken, 466-8650, Japan
-
Kindai University Hospital /ID# 266016
Sakai-shi, Osaka, 590-0197, Japan
-
Mayo Clinic - Rochester /ID# 262807
Rochester, Minnesota, 55905-0001, United States
-
Mayo Clinic Arizona /ID# 260799
Phoenix, Arizona, 85054, United States
-
Mayo Clinic Hospital Jacksonville /ID# 262808
Jacksonville, Florida, 32224, United States
-
Sylvester Comprehensive Cancer Center /ID# 260798
Miami, Florida, 33136-1002, United States
-
Tel Aviv Sourasky Medical Center /ID# 261525
Tel Aviv, Tel Aviv, 6423906, Israel
-
The Chaim Sheba Medical Center /ID# 261699
Ramat Gan, Tel Aviv, 5265601, Israel
-
Universitaetsklinikum Frankfurt /ID# 260442
Frankfurt am Main, Hesse, 60590, Germany
-
Universitaetsklinikum Hamburg-Eppendorf /ID# 260444
Hamburg, 20246, Germany
-
Universitaetsklinikum Koeln /ID# 260445
Cologne, North Rhine-Westphalia, 50937, Germany
-
University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 261050
Ann Arbor, Michigan, 48109, United States
-
Wisconsin Medical Center /ID# 261085
Milwaukee, Wisconsin, 53226, United States
Conditions
Explore the condition pages connected to this study.